Keith B. Glaser
Impact in
- Biotechnology top 0.5%
- Marine Sponges and Natural Products
- Pharmacology top 0.5%
- Microbial Natural Products and Biosynthesis
- Inflammatory mediators and NSAID effects
Papers in
-
- Histone Deacetylase Inhibitors Research 17
- Protein Degradation and Inhibitors 17
- Oncology 24
- Cancer-related Molecular Pathways 6
- Co-authors
- Steven K. Davidsen (29 shared papers)Robert S. Jacobs (8 shared papers)Alejandro M. S. Mayer (21 shared papers)Michael J. Staver (4 shared papers)Jeffrey F. Waring (3 shared papers)Roger G. Ulrich (1 shared paper)Joshua D. Stender (1 shared paper)Michael L. Curtin (14 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (17 papers)The FASEB Journal (11 papers)Inflammation Research (9 papers)Biochemical Pharmacology (8 papers)Journal of Pharmacology and Experimental Therapeutics (6 papers)
- Partner nations
- United StatesUnited KingdomSingapore
In The Last Decade
Keith B. Glaser
104 papers receiving 4.7k citations
Keith B. Glaser's Hit Papers
Peers
Comparison fields: 5 of 130
- Biotechnology 549
- Pharmacology 805
- Molecular Biology 2.7k
- Immunology 618
- Geriatrics and Gerontology 92
Countries citing papers authored by Keith B. Glaser
This map shows the geographic impact of Keith B. Glaser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith B. Glaser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith B. Glaser more than expected).
Fields of papers citing papers by Keith B. Glaser
This network shows the impact of papers produced by Keith B. Glaser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith B. Glaser. The network helps show where Keith B. Glaser may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith B. Glaser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The odyssey of marine pharmaceuticals: a current pipeline perspective Hit paper breakdown → | 2010 | 446 |
| 2 | Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. | 2003 | 445 |
| 3 | 2007 | 294 | |
| 4 | 1993 | 214 | |
| 5 | 2003 | 181 | |
| 6 | 1990 | 178 | |
| 7 | 1989 | 143 | |
| 8 | 2009 | 139 | |
| 9 | 1995 | 132 | |
| 10 | 2002 | 117 | |
| 11 | 1990 | 109 | |
| 12 | 2002 | 97 | |
| 13 | 2011 | 95 | |
| 14 | 1989 | 95 | |
| 15 | 2007 | 91 | |
| 16 | 1986 | 91 | |
| 17 | 1993 | 90 | |
| 18 | 2009 | 90 | |
| 19 | 1998 | 87 | |
| 20 | 2004 | 71 |
About Keith B. Glaser
Keith B. Glaser is a scholar working on Molecular Biology, Oncology, Hematology, Pharmacology and Immunology, having authored 108 papers that have together received 4.9k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (17 papers), Protein Degradation and Inhibitors (17 papers), Acute Myeloid Leukemia Research (11 papers), Microtubule and mitosis dynamics (9 papers), Science, Research, and Medicine (8 papers), Inflammatory mediators and NSAID effects (8 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Biotechnology (549 citations), Pharmacology (805 citations), Molecular Biology (2.7k citations), Immunology (618 citations) and Geriatrics and Gerontology (92 citations). Keith B. Glaser has collaborated with scholars based in United States, United Kingdom and Singapore. Frequent co-authors include Steven K. Davidsen, Robert S. Jacobs, Alejandro M. S. Mayer, Michael J. Staver, Jeffrey F. Waring, Roger G. Ulrich, Joshua D. Stender, Michael L. Curtin, Patrick A. Marcotte and Richard J. Ulevitch. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, The FASEB Journal, Inflammation Research, Biochemical Pharmacology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.